EN
HI
Summary
As of 28 Aug, 2026, Zydus Lifesciences stock price is ₹1191. During the trading session, the stock has moved between an intraday low of ₹1170.60 and an intraday high of ₹1198.90. Over the last 52 weeks, Zydus Lifesciences has traded between ₹835.50 and ₹1205.00.
The stock has recorded a trading volume of 12,91,738 shares, with a market capitalization of ₹1006233990. Its Average Traded Price (ATP) is ₹1180.20, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 68 @ ₹1191.00.
Zydus Lifesciences has an upper circuit limit of ₹1308.10 and a lower circuit limit of ₹1070.30. The total value traded stands at ₹152.45 CR, and the delivery percentage for the day is 49.63%.
The stock is currently traded with a market lot size of 1. Zydus Lifesciences also offers a dividend yield of 0.08%.
Zydus Lifesciences share price chart
Zydus Lifesciences Share Key Metrics
Volume
12.92 L
Market Cap
119842.47 CR
LTQ@LTP
68@1191.00
ATP
1180.2
Var Margin
13.2 %
Circuit Range
1070.3-1308.1
Delivery %
49.63 %
Value
152.45 CR
ASM/GSM
No
Market Lot
1
Zydus Lifesciences Fundamentals
P/E Ratio
26.28
P/B Ratio
4.4
Div. Yield
0.08
Sector P/E
68.56
Sector P/B
3.39
Sec. Div. Yield
0.51
Zydus Lifesciences Resistance and Support
Pivot 1175.57
Resistance
First Resistance
1209.04
Second Resistance
1228.87
Third Resistance
1262.34
Support
First Support
1155.74
Second Support
1122.27
Third Support
1102.44
Zydus Lifesciences Futures & Options
Zydus Lifesciences Option Chain
View Price, OI, Greeks & More...
29SEP26
1190.80
-7.70 (0.64%)
27OCT26
1197.80
-4.90 (0.41%)
23NOV26
1204.80
-5.90 (0.49%)
ZYDUSLIFE|29SEP26 CE 1190.00
29.40
-4.65 (-13.66%)
ZYDUSLIFE|29SEP26 PE 1200.00
33.2
2.35 (7.62%)
Zydus Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 28 2026 | 1190 | 1191 | 0.15% | 1198.9 | 1170.6 |
| Thu Aug 27 2026 | 1160 | 1189.19 | 3.41% | 1195.4 | 1142.09 |
| Wed Aug 26 2026 | 1127.4 | 1150 | 2.27% | 1150.5 | 1117.8 |
Zydus Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Fund raising |
| 2025-08-12 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
Zydus Lifesciences News
Zydus Lifesciences Ltd - 532321 - Incorporation Of A Wholly Owned Subsidiary In Gift City, Gandhinagar, Gujarat
Zydus Lifesciences Limited has incorporated a new wholly-owned subsidiary, Zydus Global Treasury Centre IFSC Limited, in Gift City, Gandhinagar. The new entity will undertake global and regional corporate treasury activities.
Aug 26 2026 11:15:50
Zydus Lifesciences Ltd - 532321 - ESG Rating
Zydus Life Science has been assigned an overall Environment, Social and Governance (ESG) score of 66 by CRISIL Ratings for FY25-26. This marks an improvement from the previous score of 61, with CRISIL considering scores between 61-70 as 'strong'.
Aug 25 2026 17:40:42
Read More
Zydus Lifesciences Management
| Name | Position |
|---|---|
| Dhaval N Soni | Company Secretary & Compliance Officer |
| Pankaj R Patel | Chairman |
Zydus Lifesciences Similar Stocks
Sun Pharmaceutical Industries Ltd.
1920.00
6.70 (0.35%)
Divi's Laboratories Ltd.
9239.00
179.00 (1.98%)
Torrent Pharmaceuticals Ltd.
5050.00
51.00 (1.02%)
Apollo Hospitals Enterprise Ltd.
8838.50
38.50 (0.44%)
Cipla Ltd.
1423.50
3.50 (0.25%)
Lenskart Solutions Ltd.
636.15
-4.45 (0.69%)
Manipal Health Enterprises Ltd.
771.65
-26.30 (3.30%)
Laurus Labs Ltd.
1938.50
9.10 (0.47%)
Lupin Ltd.
2171.50
13.40 (0.62%)
Dr. Reddy's Laboratories Ltd.
1178.00
1.00 (0.08%)
Zydus Lifesciences FAQs
The Buying Price of Zydus Lifesciences share is 1191 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Zydus Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Zydus Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Zydus Lifesciences shares is 26.28. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Zydus Lifesciences shares is 4.4. Useful to assess the stock's value relative to its book value.
To assess Zydus Lifesciences’s valuation compare Sector P/E, P/B which are 68.56 & 3.39 with sector averages, along with growth rates and financial metrics.
The Market Cap of Zydus Lifesciences is 119842.47 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Zydus Lifesciences share price is 1205.00 & 835.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Zydus Lifesciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
